OPERO
ActiveFrom the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
OPERO has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,049 and a net result of €130,586. Equity has been shrinking by about 59% per year since 2021. Its solvency ranks better than 15% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
KBO- Status
- Active since 05-01-2021 Normal situation
- Activity
- Research and development on biotechnology NACE 72101and 5 others
- Establishment unit
- 2.311.695.684 1851 Grimbergen, since 05-01-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 26-07-2024
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €168,579
- ▼ 22.3%
- Turnover
- ≈ €420,000
- estimated
- Profit
- €130,586
- ▼ 21.4%
- Equity
- €5,049
- ▼ 46.6%
- Total assets
- €225,981
- ▲ 15.3%
Score breakdownraises riskEquity €5,049 (2.2% of total assets)lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 1.02, cash €156,608Size: total assets €225,981Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 19% of them on solvency, 28% on liquidity, 90% on profitability and 16% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 89 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as OPERO: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €128,000 and €369,000, founded between 2019 and 2021.
| Company | Total assets | Gross margin |
|---|---|---|
| OPERO Grimbergen | €225,981 | €168,579 |
| DILMA CONSULT Overijse | €127,819 | €145,578 |
| SciLife Consulting Kortenberg | €198,474 | €77,658 |
| Vertommen Johan Holsbeek | €369,058 | €105,701 |
| Huysse MedConsult Boutersem | €144,769 | €81,892 |
| Bayoclin Nivelles | €269,763 | €240,138 |
| BONT Kasterlee | €307,284 | €152,933 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 12-03-2026
- Annual accounts 2024filed on 17-02-2025
- Annual accounts 2023filed on 02-04-2024
- Annual accounts 2022filed on 25-07-2023
Acts in the Belgian Official Gazette
All publications in the Belgian Official GazetteArticles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about OPERO
- What is the company number of OPERO?
- The company number of OPERO is 0760.816.827. The VAT number is the same number with BE in front: BE 0760.816.827.
- Where is OPERO based?
- The registered office is at Bintjeshof 1, 1851 Grimbergen.Company details
- What does OPERO do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of OPERO?
- The legal form of OPERO is Private limited company (BV).
- When was OPERO founded?
- OPERO was founded on 05-01-2021.
- Is OPERO still active?
- Yes, OPERO is an active enterprise in the KBO register.
- What is the turnover of OPERO?
- The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €168,579 and 2,213 comparable companies of the same size. It probably lies between €280,000 and €650,000. It is a rough estimate.Financials
- Is OPERO profitable?
- In financial year 2025, OPERO made a profit of €130,586.
- Where can I find the annual accounts of OPERO?
- OPERO filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of OPERO due?
- OPERO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.